4129 Stock Overview
Engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
United Orthopedic Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$93.40 |
| 52 Week High | NT$114.00 |
| 52 Week Low | NT$82.40 |
| Beta | 0.70 |
| 1 Month Change | -4.21% |
| 3 Month Change | -2.20% |
| 1 Year Change | 8.86% |
| 3 Year Change | 199.36% |
| 5 Year Change | 110.36% |
| Change since IPO | 562.41% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)
Apr 26
United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital
Apr 12What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Mar 08Is United Orthopedic (GTSM:4129) A Risky Investment?
Feb 16
Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?
Jan 29Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)
Jan 11Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Dec 24How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 03Shareholder Returns
| 4129 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 0.1% | 0.3% | 0.4% |
| 1Y | 8.9% | -4.5% | 28.7% |
Return vs Industry: 4129 exceeded the TW Medical Equipment industry which returned -4.5% over the past year.
Return vs Market: 4129 underperformed the TW Market which returned 28.7% over the past year.
Price Volatility
| 4129 volatility | |
|---|---|
| 4129 Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4129 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4129's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | n/a | www.unitedorthopedic.com |
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine products consisting of vertebral fixation devices. It also provides injury and other orthopedic products comprise orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; OEM products, such as orthopedic internal fixation; and lamb salvage systems.
United Orthopedic Corporation Fundamentals Summary
| 4129 fundamental statistics | |
|---|---|
| Market cap | NT$8.99b |
| Earnings (TTM) | NT$453.71m |
| Revenue (TTM) | NT$4.47b |
19.8x
P/E Ratio2.0x
P/S RatioIs 4129 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4129 income statement (TTM) | |
|---|---|
| Revenue | NT$4.47b |
| Cost of Revenue | NT$987.91m |
| Gross Profit | NT$3.48b |
| Other Expenses | NT$3.03b |
| Earnings | NT$453.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.71 |
| Gross Margin | 77.91% |
| Net Profit Margin | 10.15% |
| Debt/Equity Ratio | 45.3% |
How did 4129 perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield83%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 20:13 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
United Orthopedic Corporation is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pinghan Hsieh | Capital Securities Corporation |
| Jennie Tsai | G. Research, LLC |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |